このエントリーをはてなブックマークに追加


ID 32303
JaLCDOI
FullText URL
fulltext.pdf 1.25 MB
Author
Ogawa, Norio
Abstract

Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD. To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms, levodopa therapy should be conducted by taking these factors into consideration.

Keywords
dopamine agonist
monoamine oxidase-B(MAO-B) inhibitor
catechol-O-methyltransferase(COMT)inhibitor
blood-brain barrier
age at onset
large neutral amino acids
gastric acidity
Amo Type
Review
Publication Title
Acta Medica Okayama
Published Date
2000-06
Volume
volume54
Issue
issue3
Publisher
Okayama University Medical School
Start Page
95
End Page
101
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT